Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Lipton

Showing results (701-710 of 832) with videos related to

Pageof 84
Sort By:
International Journal of Cardiology|April 28, 2007
High-frequency QRS electrocardiogram analysis during exercise stress testing for detecting ischemiaJonathan A Lipton, Stafford G Warren, Mike Broce, et al.
The Journal of Clinical Endocrinology and Metabolism|July 1, 1991
Specificity of low dose fadrozole hydrochloride (CGS 16949A) as an aromatase inhibitorR J Santen, L M Demers, J Lynch, et al.
Journal of Neurophysiology|November 16, 2007
Modulation of NMDA receptor properties and synaptic transmission by the NR3A subunit in mouse hippocampal and cerebrocortical neuronsGary Tong, Hiroto Takahashi, Shichun Tu, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 23, 2002
Caspase cascades in human immunodeficiency virus-associated neurodegenerationGwenn A Garden, Samantha L Budd, Elena Tsai, et al.
Cancer|April 3, 2001
Zoledronic acid reduces skeletal-related events in patients with osteolytic metastasesJ R Berenson, L S Rosen, A Howell, et al.
Cancer|June 1, 1984
Nonmedical costs to patients and their families associated with outpatient chemotherapyP S Houts, A Lipton, H A Harvey, et al.
Angewandte Chemie (International Ed. in English)|November 27, 2010
Synthesis of higher diamondoids and implications for their formation in petroleumJeremy E P Dahl, J Michael Moldowan, Zhibin Wei, et al.
Cancer|March 15, 1990
A phase I trial of CGS 16949A. A new aromatase inhibitorA Lipton, H A Harvey, L M Demers, et al.
Cancer|June 1, 1977
Immunosuppression and human cancer: role of prostaglandinsH A Harvey, J C Allegra, L M Demers, et al.
Neurobiology of Disease|March 23, 2015
Aberrant protein S-nitrosylation contributes to the pathophysiology of neurodegenerative diseasesTomohiro Nakamura, Olga A Prikhodko, Elaine Pirie, et al.
Pageof 84

Showing results (701-710 of 832) with videos related to

Sort By:
Pageof 84
International Journal of Cardiology|April 28, 2007
High-frequency QRS electrocardiogram analysis during exercise stress testing for detecting ischemiaJonathan A Lipton, Stafford G Warren, Mike Broce, et al.
The Journal of Clinical Endocrinology and Metabolism|July 1, 1991
Specificity of low dose fadrozole hydrochloride (CGS 16949A) as an aromatase inhibitorR J Santen, L M Demers, J Lynch, et al.
Journal of Neurophysiology|November 16, 2007
Modulation of NMDA receptor properties and synaptic transmission by the NR3A subunit in mouse hippocampal and cerebrocortical neuronsGary Tong, Hiroto Takahashi, Shichun Tu, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 23, 2002
Caspase cascades in human immunodeficiency virus-associated neurodegenerationGwenn A Garden, Samantha L Budd, Elena Tsai, et al.
Cancer|April 3, 2001
Zoledronic acid reduces skeletal-related events in patients with osteolytic metastasesJ R Berenson, L S Rosen, A Howell, et al.
Cancer|June 1, 1984
Nonmedical costs to patients and their families associated with outpatient chemotherapyP S Houts, A Lipton, H A Harvey, et al.
Angewandte Chemie (International Ed. in English)|November 27, 2010
Synthesis of higher diamondoids and implications for their formation in petroleumJeremy E P Dahl, J Michael Moldowan, Zhibin Wei, et al.
Cancer|March 15, 1990
A phase I trial of CGS 16949A. A new aromatase inhibitorA Lipton, H A Harvey, L M Demers, et al.
Cancer|June 1, 1977
Immunosuppression and human cancer: role of prostaglandinsH A Harvey, J C Allegra, L M Demers, et al.
Neurobiology of Disease|March 23, 2015
Aberrant protein S-nitrosylation contributes to the pathophysiology of neurodegenerative diseasesTomohiro Nakamura, Olga A Prikhodko, Elaine Pirie, et al.
Pageof 84